Intrinsic Value of S&P & Nasdaq Contact Us

Inogen, Inc. INGN NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$26.00
+310.1%

Inogen, Inc. (INGN) has a consensus analyst rating of Buy, based on 11 analysts covering the stock. Of those, 6 recommend buying, 4 recommend holding, and 1 recommend selling.

The analyst consensus price target for INGN is $26.00, representing a +310.1% upside from the current price of $6.34. Price targets range from a low of $26.00 to a high of $26.00.

Analyst Consensus — INGN

Buy
Strong Buy
0
Buy
6
Hold
4
Sell
1
Strong Sell
0
11 analysts
Price Targets
Consensus$26.00
High$26.00
Low$26.00
Median$26.00
Last Month Avg-
Last Quarter Avg-
Last Year Avg-
All-Time Count1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message